Sarah A. O'Dowd - 16 Jan 2023 Form 4 Insider Report for Protagonist Therapeutics, Inc (PTGX)

Role
Director
Signature
/s/ Asif Ali, Attorney-in-Fact for Sarah A. O'Dowd
Issuer symbol
PTGX
Transactions as of
16 Jan 2023
Transactions value $
$0
Form type
4
Filing time
18 Jan 2023, 19:00:48 UTC
Previous filing
27 May 2022
Next filing
22 May 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PTGX Stock Option (right to buy) Award $0 +30,000 $0.000000 30,000 16 Jan 2023 Common Stock 30,000 $12.17 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests in 12 equal monthly installments following the date of grant.

Remarks:

Exhibit 24 - Power of Attorney